Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis

Abstract. Phenotypic modulation, migration and proliferation of vascular smooth muscle cells (SMCs) are major events in restenosis after percutaneous transluminal angioplasty. Surface cell adhesion molecules, essential to morphogenesis and maintenance of adult tissue architecture, are likely to be involved, but little is known about cell adhesion molecules expressed on SMCs. T-cadherin is a glycosyl phosphatidylinositol-anchored member of the cadherin superfamily of adhesion molecules. Although highly expressed in vascular and cardiac tissues, its function in these tissues is unknown. We previously reported increased expression of T-cadherin in intimal SMCs in atherosclerotic lesions and proposed a role for T-cadherin in phenotype control. Here we performed immunohistochemical analysis of spatial and temporal changes in vascular T-cadherin expression following balloon catheterisation of the rat carotid artery. T-cadherin expression in SMCs markedly increases in the media early (1–4 days) after injury, and later (day 7–28) in forming neointima, especially in its preluminal area. Staining for monocyte/macrophage antigen ED-1, proliferating cell nuclear antigen and smooth muscle alpha-actin revealed that spatial and temporal changes in T-cadherin level coincided with the peak in cell migration and proliferation activity during neointima formation. In colchicine-treated cultures of rat aortic SMCs T-cadherin expression is increased in dividing M-phase cells but decreased in non-dividing cells. Together the data support an association between T-cadherin expression and SMC phenotype.

[1]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[2]  O. Kocher,et al.  H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. , 1998, Carcinogenesis.

[3]  B. Ranscht,et al.  T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.

[4]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[5]  E. Anggard,et al.  Arterial response to mechanical injury: balloon catheter de-endothelialization. , 1992, Atherosclerosis.

[6]  M. Philippova,et al.  Identification of an atypical lipoprotein‐binding protein from human aortic smooth muscle as T‐cadherin , 1998, FEBS letters.

[7]  B. Angst,et al.  COMMENTARY The cadherin superfamily: diversity in form and function , 2022 .

[8]  S. Schwartz,et al.  Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.

[9]  F. Lauwers,et al.  Identification of macrophages in intimal thickening of rat carotid arteries by cytochemical localization of purine nucleoside phosphorylase. , 1988, Arteriosclerosis.

[10]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[11]  D. Adams,et al.  Leucocyte-endothelial interactions and regulation of leucocyte migration , 1994, The Lancet.

[12]  M. Philippova,et al.  T‐cadherin and signal‐transducing molecules co‐localize in caveolin‐rich membrane domains of vascular smooth muscle cells , 1998, FEBS letters.

[13]  Y. Ohtsuki,et al.  H‐cadherin expression in breast cancer , 1999, Histopathology.

[14]  Y. Ohtsuki,et al.  Expression of T‐Cadherin (CDH13, H‐Cadherin) in Human Brain and Its Characteristics as a Negative Growth Regulator of Epidermal Growth Factor in Neuroblastoma Cells , 2000, Journal of neurochemistry.

[15]  M. Ringwald,et al.  Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Ratliff,et al.  Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. , 1985, Journal of the American College of Cardiology.

[17]  R. Klemenz,et al.  Advances in Brief Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels 1 , 2022 .

[18]  S. Gilbertson-Beadling,et al.  A potential role for N-cadherin in mediating endothelial cell-smooth muscle cell interactions in the rat vasculature. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[19]  C. Redies,et al.  N‐cadherin mediates pericytic‐endothelial interaction during brain angiogenesis in the chicken , 2000 .

[20]  P. Hervé,et al.  Screening of five specific cell cycle inhibitors using a T cell lymphoma cell line synchrony/release assay. , 1999, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[21]  E. Koller,et al.  Differential Targeting of T- and N-cadherin in Polarized Epithelial Cells* , 1996, The Journal of Biological Chemistry.

[22]  O. Blaschuk,et al.  An N‐cadherin–like protein contributes to solute barrier maintenance in cultured endothelium , 1993, Journal of cellular physiology.

[23]  B. Ranscht,et al.  Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium- dependent, homophilic cell adhesion , 1992, The Journal of cell biology.

[24]  B. Fredette,et al.  Inhibition of motor axon growth by T-cadherin substrata. , 1996, Development.

[25]  Schwartz Sm,et al.  Endothelial regeneration. II. Restitution of endothelial continuity. , 1979 .

[26]  G. Odland,et al.  HUMAN WOUND REPAIR , 1968, Journal of Cell Biology.

[27]  T. Niermann,et al.  LDL binds to surface‐expressed human T‐cadherin in transfected HEK293 cells and influences homophilic adhesive interactions , 1999, FEBS letters.

[28]  F. Haselton,et al.  Role of cadherins 5 and 13 in the aortic endothelial barrier , 1997, Journal of cellular physiology.

[29]  G. Goings,et al.  T-cadherin Is a Major Glycophosphoinositol-anchored Protein Associated with Noncaveolar Detergent-insoluble Domains of the Cardiac Sarcolemma* , 1998, The Journal of Biological Chemistry.

[30]  T. Niermann,et al.  The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins. , 2000, Biochemical and biophysical research communications.

[31]  E J Topol,et al.  Experimental models of coronary artery restenosis. , 1992, Journal of the American College of Cardiology.

[32]  L. Hartmann,et al.  Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. , 1999, International journal of oncology.

[33]  M. Takeichi,et al.  A potential role of R-cadherin in striated muscle formation. , 1997, Developmental biology.

[34]  S. London,et al.  Kinetics of bromodeoxyuridine uptake by smooth muscle cells after arterial injury. , 1994, Journal of vascular research.

[35]  M. Philippova,et al.  Identification of 130 kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor. , 1999, Biochimica et biophysica acta.

[36]  Sam W. Lee.  H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer , 1996, Nature Medicine.

[37]  P. Erne,et al.  Expression of cell adhesion molecule T-cadherin in the human vasculature , 2001, Histochemistry and Cell Biology.

[38]  M. Lewis,et al.  Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[39]  O. Blaschuk,et al.  Identification of a cadherin cell adhesion recognition sequence. , 1990, Developmental biology.

[40]  M. Corada,et al.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. Webster,et al.  Experimental aortic intimal thickening. I. Morphology and source of intimal cells. , 1974, The American journal of pathology.

[42]  A. Yap,et al.  The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. , 1998, Cancer investigation.

[43]  V. Tkachuk,et al.  Density‐ and proliferation status‐dependent expression of T‐cadherin, a novel lipoprotein‐binding glycoprotein: a function in negative regulation of smooth muscle cell growth? , 1998, FEBS letters.

[44]  B. Fredette,et al.  T-cadherin expression delineates specific regions of the developing motor axon-hindlimb projection pathway , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  M. Gerritsen,et al.  Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. , 1999, The American journal of pathology.

[46]  E. Topol,et al.  Cell adhesion molecules in coronary artery disease. , 1994, Journal of the American College of Cardiology.

[47]  M. Lampugnani,et al.  A novel endothelial-specific membrane protein is a marker of cell-cell contacts , 1992, The Journal of cell biology.

[48]  T. Resink,et al.  Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. , 1989, Hypertension.